ask="N/A"
ask_size="N/A"
average_daily_volume="57655"
bid="14.00"
bid_size="1000"
book_value="6.38"
change="+0.25"
change_from_200_day_moving_average="0.21"
change_from_50_day_moving_average="-0.51"
change_from_52_week_high="-4.17"
change_From_52_week_low="3.51"
change_in_percent="+1.53%"
close="16.57"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-8.72"
ebitda="-48.18M"
eps_estimate_current_year="-4.11"
eps_estimate_next_quarter="-0.77"
eps_estimate_next_year="-3.46"
ex_dividend_date="N/A"
float_shares="6846000"
high="16.61"
high_52_weeks="20.74"
last_trade_date="2/1/2017"
last_trade_price="16.57"
last_trade_size="1725"
last_trade_time="4:00pm"
low="16.19"
low_52_weeks="13.06"
market_capitalization="359.98M"
moving_average_200_day="16.36"
moving_average_50_day="17.08"
name="Audentes Therapeutics
Inc."
notes="N/A"
one_year_target_price="22.33"
open="16.42"
pe_ratio="N/A"
peg_ratio="-1.45"
percent_change_from_200_day_moving_average="+1.29%"
percent_change_from_50_day_moving_average="-2.98%"
percent_change_from_52_week_high="-20.11%"
percent_change_from_52_week_low="+26.88%"
previous_close="16.32"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.56"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21725000"
short_ratio="5.12"
stock_exchange="NGM"
symbol="BOLD"
volume="36992"
weeks_range_52="13.06 - 20.74"
